Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

NCT02202772 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma of the Urinary Bladder

Interventions

DRUG: Cabazitaxel
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Guarionex J. Decastro

Collaborators

[object Object]